The study investigated the prevalence and all-cause mortality of tricuspid regurgitation across heart failure phenotypes, but no quantitative results were reported in the abstract.
Observational
What is the prevalence and impact on all-cause mortality of different grades of tricuspid regurgitation across HFrEF, HFmrEF, and HFpEF phenotypes?
This study aims to characterize the prevalence and mortality risk of tricuspid regurgitation across the full spectrum of heart failure phenotypes.
ignificant tricuspid regurgitation (TR), the most common secondary functional TR, is a frequent finding associated with substantial mortality. 1 Recent studies focused on TR in mixed heart failure (HF) populations or subgroups, but did not compare heart failure with reduced ejection fraction (HFrEF), heart failure with mildly reduced ejection fraction (HFmrEF), and heart failure with preserved ejection fraction (HFpEF). 1,2 Since novel interventional therapies have predominantly been used in HFpEF, a comprehensive understanding of TR across all HF phenotypes is crucial to identify patients at risk for TR-related adverse events. The present study investigated the prevalence and all-cause mortality in patients with different TR grades and HF phenotypes.
Mattig et al. (Wed,) conducted a observational in Heart Failure and Tricuspid Regurgitation. Tricuspid regurgitation vs. Different TR grades and HF phenotypes was evaluated on Prevalence and all-cause mortality. The study investigated the prevalence and all-cause mortality of tricuspid regurgitation across heart failure phenotypes, but no quantitative results were reported in the abstract.